MARKET

GCVRZ

GCVRZ

Sanofi FR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8555
+0.0002
+0.02%
Closed 16:00 11/21 EST
OPEN
0.8551
PREV CLOSE
0.8553
HIGH
0.8557
LOW
0.8550
VOLUME
8.00K
TURNOVER
--
52 WEEK HIGH
0.8600
52 WEEK LOW
0.1529
MARKET CAP
1.07B
P/E (TTM)
0.3102
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GCVRZ and other stocks commission-free!

Open a Webull account and fund it to get a free stock

GCVRZ News

  • Exclusive: Sanofi's strategy boss to leave as CEO readies revamp
  • Reuters.2h ago
  • Takeda Pharmaceuticals: Be Careful Investing In Its Dengue Vaccine
  • Seeking Alpha - Article.21h ago
  • Sanofi Is Said to Mull Options for $30 Billion Consumer Arm
  • Bloomberg.22h ago
  • Sanofi's Positive Diabetes Study Offers A New Treatment Alternative For Patients
  • Seeking Alpha - Article.22h ago

More

Industry

Pharmaceuticals
+0.60%
Pharmaceuticals & Medical Research
+0.39%

Hot Stocks

Name
Price
%Change

About GCVRZ

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
More

Webull offers Sanofi SA (GCVRZ) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.